Praxis Precision Medicines (PRAX) Tops Q1 EPS by 40c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q1 EPS of ($3.20), $0.40 better than the analyst estimate of ($3.60).

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Jack Henry (JKHY) Tops Q4 EPS by 13c
• 374Water Inc (SCWO) Misses Q2 EPS by 15c